Literature DB >> 22962511

Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P(2) Purinoceptors: Heterogeneity Within P(2X) and P(2Y) Subtypes.

Geoffrey Burnstock1, Bilha Fischer, Charles H V Hoyle, Michel Maillard, Airat U Ziganshin, Antonia L Brizzolara, Amy von Isakovics, José L Boyer, T Kendall Harden, Kenneth A Jacobson.   

Abstract

The structure-activity relationships for a variety of adenine nucleotide analogues at P(2x)- and P(2Y)-purinoceptors were investigated. Compounds formed by structural modifications of the ATP molecule including substitutions of the purine ring (C2, C8, N1, and N(6)-substituents, and a uridine base instead of adenine), the ribose moiety (2' and 3'-positions), and the triphosphate group (lower phosphates, bridging oxygen substitution, and cyclization) were prepared. Pharmacological activity at P(2Y)-purinoceptors was assayed in the guinea pig taenia coli, endothelial cells of the rabbit aorta, smooth muscle of the rabbit mesenteric artery, and turkey erythrocyte membranes. Activity at P(2X)-purinoceptors was assayed in the rabbit saphenous artery and the guinea-pig vas deferens and urinary bladder. Some of the analogues displayed selectivity, or even specificity, for either the P(2X)- or the P(2Y)-purinoceptors. Certain analogues displayed selectivity or specificity within the P(2X)- or P(2Y)-purinoceptor superfamilies, giving hints about possible subclasses. For example, 8-(6-aminohexylamino)ATP and 2',3'-isopropylidene-AMP were selective for endothelial Pzypurinoceptors over P(2Y)-purinoceptors in the guinea pig taenia coli, rabbit aorta, and turkey erythrocytes. These compounds were both inactive at P(2X)-purinoceptors. The potent agonist N(6)-methyl ATP and the somewhat less potent agonist 2'-deoxy-ATP were selective for P(2Y)-purinoceptors in the guinea pig taenia coli, but were inactive at P(2X)-purinoceptors and the vascular P(2Y)-purinoceptors. 3'-Benzylamino-3'-deoxyATP was very potent at the P(2X)-purinoceptors in the guinea pig vas deferens and bladder, but not in the rabbit saphenous artery and was inactive at P(2Y) receptors. These data suggest that specific compounds can be developed that can be utilized to activate putative subtypes of the P(2X)- and P(2Y)-purinoceptor classes.

Entities:  

Year:  2004        PMID: 22962511      PMCID: PMC3434461          DOI: 10.1002/ddr.430310308

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  44 in total

1.  Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides.

Authors:  I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

Review 2.  Purinergic nerves.

Authors:  G Burnstock
Journal:  Pharmacol Rev       Date:  1972-09       Impact factor: 25.468

3.  TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A1 ADENOSINE RECEPTOR.

Authors:  Kenneth A Jacobson; Mark E Olah; Gary L Stiles
Journal:  Pharmacol Commun       Date:  1992

4.  Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes.

Authors:  T K Harden; P T Hawkins; L Stephens; J L Boyer; C P Downes
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

5.  Comparison of P2 purinergic receptors of aortic endothelial cells with those of adrenal medulla: evidence for heterogeneity of receptor subtype and of inositol phosphate response.

Authors:  D J Allsup; M R Boarder
Journal:  Mol Pharmacol       Date:  1990-07       Impact factor: 4.436

6.  ATP mediates fast synaptic transmission in mammalian neurons.

Authors:  R J Evans; V Derkach; A Surprenant
Journal:  Nature       Date:  1992-06-11       Impact factor: 49.962

7.  Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.

Authors:  C H Hoyle; G A Edwards
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

8.  Guanine nucleotide-sensitive interaction of a radiolabeled agonist with a phospholipase C-linked P2y-purinergic receptor.

Authors:  C L Cooper; A J Morris; T K Harden
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Cloning and functional expression of a brain G-protein-coupled ATP receptor.

Authors:  T E Webb; J Simon; B J Krishek; A N Bateson; T G Smart; B F King; G Burnstock; E A Barnard
Journal:  FEBS Lett       Date:  1993-06-14       Impact factor: 4.124

10.  Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.

Authors:  B Fischer; J L Boyer; C H Hoyle; A U Ziganshin; A L Brizzolara; G E Knight; J Zimmet; G Burnstock; T K Harden; K A Jacobson
Journal:  J Med Chem       Date:  1993-11-26       Impact factor: 7.446

View more
  20 in total

1.  Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.

Authors:  R Gnana Ravi; Hak Sung Kim; Jörg Servos; Herbert Zimmermann; Kyeong Lee; Savitri Maddileti; José L Boyer; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

2.  A Photo-clickable ATP-Mimetic Reveals Nucleotide Interactors in the Membrane Proteome.

Authors:  Mark Jelcic; Ke Wang; King Lam Hui; Xiao-Chuan Cai; Balázs Enyedi; Minkui Luo; Philipp Niethammer
Journal:  Cell Chem Biol       Date:  2020-06-09       Impact factor: 8.116

3.  Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.

Authors:  R Bültmann; O Dudeck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

4.  Modelling the P2Y purinoceptor using rhodopsin as template.

Authors:  A M Van Rhee; B Fischer; P J Van Galen; K A Jacobson
Journal:  Drug Des Discov       Date:  1995-11

5.  Demystifying P2Y1 Receptor Ligand Recognition through Docking and Molecular Dynamics Analyses.

Authors:  Antonella Ciancetta; Robert D O'Connor; Silvia Paoletta; Kenneth A Jacobson
Journal:  J Chem Inf Model       Date:  2017-11-28       Impact factor: 4.956

6.  Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.

Authors:  Enrica Calleri; Stefania Ceruti; Gloria Cristalli; Claudia Martini; Caterina Temporini; Chiara Parravicini; Rosaria Volpini; Simona Daniele; Gabriele Caccialanza; Davide Lecca; Catia Lambertucci; Maria Letizia Trincavelli; Gabriella Marucci; Irving W Wainer; Graziella Ranghino; Piercarlo Fantucci; Maria P Abbracchio; Gabriella Massolini
Journal:  J Med Chem       Date:  2010-05-13       Impact factor: 7.446

7.  P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin.

Authors:  R Bültmann; H Wittenburg; B Pause; G Kurz; P Nickel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

Review 8.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

9.  Identification of hydrolytically stable and selective P2Y(1) receptor agonists.

Authors:  Shay E Eliahu; Jean Camden; Joanna Lecka; Gary A Weisman; Jean Sévigny; Sylvie Gélinas; Bilha Fischer
Journal:  Eur J Med Chem       Date:  2008-07-22       Impact factor: 6.514

10.  Development of selective agonists and antagonists of P2Y receptors.

Authors:  Kenneth A Jacobson; Andrei A Ivanov; Sonia de Castro; T Kendall Harden; Hyojin Ko
Journal:  Purinergic Signal       Date:  2008-07-04       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.